Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

IMO it doesn't make sense that the stock is not currently around $30 or above, considering how much has happened since we were at $30 a year and a half ago, I think part of it is the way the company is being managed. It would appear Dan "at this time" is not looking for a sustained higher stock price or else he would not have done this latest dilution that threw water on the Amgen deal when the company was already chock full of cash. I think Dan probably thinks it is in his best interest to keep the stock low now while he continues to accumulate via monthly purchases, so (indirectly) he has sent the signal to those shorting the stock that they should continue on as usual with aggressive positions. The question is when does he let off the brakes. Hopefully, he is setting up for a big deal with Astra Zeneca on Phase 3 cervical cancer and/or a combo deal that he will not follow with another devaluation and instead let the stock reset to a more fair higher valuation on par with ADRO.